Location History:
- Safron Walden, GB (2015 - 2016)
- Cambridge, GB (2016 - 2017)
- Essex, GB (2011 - 2021)
Company Filing History:
Years Active: 2011-2021
Title: Jussi J Kangasmetsa: Innovator in Anti-Inflammatory Compounds
Introduction
Jussi J Kangasmetsa is a notable inventor based in Essex, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act on multiple prostaglandin receptors. With a total of 16 patents to his name, his work has the potential to impact the treatment of various receptor-mediated diseases.
Latest Patents
One of his latest patents focuses on compounds that provide a general anti-inflammatory response. The invention details a compound represented as a 1-({halo-2-[(2-hydrocarbyl or substituted hydrocarbyl)oxy]phenyl}methyl)-(fused bicyclic nitrogen heteroaryl) carboxylic acid or an ester or sulfonamide thereof. The compounds may be administered to treat diseases or conditions mediated by DP, FP, EP1, TP, and/or EP4 receptors.
Career Highlights
Throughout his career, Jussi has worked with prominent companies in the pharmaceutical industry, including Allergan, Inc. and Medivir AB. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Jussi has collaborated with notable professionals in his field, including Jose L Martos and David Frederick Woodward. These collaborations have likely enriched his research and development efforts.
Conclusion
Jussi J Kangasmetsa is a distinguished inventor whose work in anti-inflammatory compounds showcases his commitment to advancing medical science. His contributions continue to pave the way for new treatments in the pharmaceutical industry.